Workflow
HELENS(09869)
icon
Search documents
海伦司涨超12% 董事会决定行使回购股份授权
Zhi Tong Cai Jing· 2025-11-07 02:03
Core Viewpoint - Helen's (09869) shares rose over 12%, reaching a price of 1.09 HKD, with a trading volume of 2.0072 million HKD, following the announcement of a share buyback plan [1] Group 1: Share Buyback Announcement - The shareholders approved a general and unconditional authorization for the board to repurchase up to 10% of the total issued shares as of the annual general meeting date, equating to a maximum of 127 million shares [1] - The board decided to exercise the buyback authorization on November 6, 2025, intending to repurchase shares in the open market using existing internal financial resources [1] - The company believes that the current trading price does not adequately reflect its intrinsic value, and the share buyback demonstrates confidence in its growth prospects and financial condition, aiming to enhance net asset value and earnings per share, which aligns with the best interests of the company and its shareholders [1]
港股异动 | 海伦司(09869)涨超12% 董事会决定行使回购股份授权
智通财经网· 2025-11-07 02:00
Core Viewpoint - The company, Helen's (09869), has seen its stock price increase by over 12%, currently trading at 1.09 HKD, with a trading volume of 2.0072 million HKD, following the announcement of a share buyback plan [1] Group 1: Share Buyback Announcement - The shareholders approved a general and unconditional authorization for the board to repurchase up to 10% of the total issued shares as of the annual general meeting date, which amounts to a maximum of 127 million shares [1] - The board has decided to exercise the buyback authorization on November 6, 2025, intending to repurchase shares in the open market using existing internal financial resources [1] - The company believes that the current trading price does not adequately reflect its intrinsic value, and the share buyback demonstrates confidence in its growth prospects and financial condition, aiming to enhance net asset value and earnings return per share, which aligns with the best interests of the company and its shareholders [1]
百济神州前三季营收同比增超4成 信利国际年内综合营收达约140亿元
Xin Lang Cai Jing· 2025-11-06 13:11
Company News - BeiGene reported total revenue of approximately $3.845 billion for the first nine months, a year-on-year increase of 43%. Adjusted net profit was approximately $693 million, marking a return to profitability. In Q3, revenue reached $1.412 billion, up 41% year-on-year, with adjusted net profit of approximately $304 million, a 489% increase year-on-year. The growth is primarily attributed to the sales increase of BeiYueZe® in the US and Europe, with the US remaining the largest market for the company. The full-year revenue guidance is set at $5.1 billion to $5.3 billion, reflecting strong growth expectations from BeiYueZe® in the US and continued expansion in Europe and other key global markets [2] - Yidu International Holdings announced an earnings upgrade, expecting a profit attributable to shareholders of approximately HKD 1.2 billion for the first half, representing an increase year-on-year [3] - Hua Hong Semiconductor reported sales revenue of $635 million for Q3 2025, a year-on-year increase of 20.7%. However, net profit decreased by 42.6% to $25.725 million [4] - Autohome's net profit attributable to the parent company for Q3 was approximately RMB 436.6 million, with online marketing and other business revenues increasing by 32.1% year-on-year [5] - Xinyi International reported a cumulative net operating income of approximately HKD 13.981 billion for the first ten months, a year-on-year decrease of about 5.3%, with October revenue at HKD 1.457 billion [6] - Dongfeng Motor Group's cumulative vehicle sales for the first ten months reached 1.501 million units, a year-on-year decline of approximately 1.6%. However, sales of new energy vehicles increased by approximately 37.1% to 421,400 units [7] - China Overseas Land & Investment reported a cumulative contracted property sales amount of approximately RMB 189.165 billion for the first ten months, a year-on-year decrease of 21.3% [8] - Poly Property Group reported a cumulative contracted sales amount of RMB 43.8 billion for the first ten months, a year-on-year decrease of 10.43% [9] - Gemdale reported a cumulative contracted sales amount of approximately RMB 9.125 billion for the first ten months, a year-on-year decrease of 43.93% [10] - Sunac China reported a cumulative contract sales amount of approximately RMB 32.77 billion for the first ten months, a year-on-year decline of 25.1% [11] - Guoyin Financial Leasing plans to purchase 1,198 units of domestic information technology computing equipment for a total consideration of RMB 1.04 billion [12] - Youjia Innovation recently received project designation notifications from a globally renowned automotive group's joint venture and luxury brand, with a total order amount of approximately RMB 320 million [13] - Swire Properties reported a rental rate of 96% for Taikoo Place in Q3, with a rental reduction of 13%. Other Swire properties had an occupancy rate of 90%, with a rental reduction of 15% [14] - Zhongshen Construction Industry plans to acquire 100% equity of Huajian Development Co., Ltd. for approximately HKD 213.6 million [15] - Hard Egg Innovation signed a memorandum of understanding with Huixin Investment to jointly develop an AIoT innovation enterprise incubation platform [16] - Damai Entertainment expects mid-term net profit to increase to no less than RMB 500 million, compared to RMB 337 million last year [17] - Cafe de Coral Group issued a profit warning, expecting mid-term profit attributable to shareholders to decline by 65% to 70% [18] - Qingci Games signed a game licensing transfer agreement with Disney, obtaining authorization to develop and publish the game "Disney: Book of Legends," expected to launch in 2026 across various regions [19] - Now Medical Technology's subsidiary signed a strategic cooperation framework agreement with Medtronic Changzhou to promote clinical applications of real-time navigation tracking endoscopic technology in China [19] - Zhaoke Ophthalmology-B signed a distribution agreement with PT FERRON for the commercialization of BRIMOCHOL PF in Indonesia, receiving an upfront payment and potential milestone payments [19] - Shoujia Technology signed a strategic framework cooperation agreement with Stardust Intelligence, covering the development of humanoid robot tendon and related fields [20] Buyback Dynamics - Helen's decided to exercise its share buyback authorization, planning to repurchase up to 127 million shares [21] - China Feihe repurchased 6.806 million shares for a total of approximately HKD 29.4298 million, with a buyback price of HKD 4.29 to HKD 4.35 [22] - Kintor Pharmaceutical repurchased 1.734 million shares for a total of approximately HKD 26.3078 million, with a buyback price of HKD 14.35 to HKD 15.8 [23] - COSCO Shipping Holdings repurchased 1.53 million shares for a total of approximately HKD 20.9869 million, with a buyback price of HKD 13.57 to HKD 13.84 [24] - Sinopec repurchased 2.398 million H-shares for a total of approximately HKD 10.1066 million, with a buyback price of HKD 4.20 to HKD 4.23 [25]
海伦司决定行使回购股份授权
Zhi Tong Cai Jing· 2025-11-06 09:12
Core Viewpoint - The company, Helen's (09869), has received shareholder approval to repurchase up to 10% of its issued shares, amounting to a maximum of 127 million shares, reflecting confidence in its growth prospects and financial health [1] Group 1 - Shareholders approved a general and unconditional authorization for the board to repurchase shares at the annual general meeting on May 14, 2025 [1] - The repurchase authorization will expire upon the earliest occurrence of several conditions, including the conclusion of the next annual general meeting in 2026 or the expiration of any applicable legal requirements [1] - On November 6, 2025, the board decided to exercise the share repurchase authorization, intending to buy back shares in the open market using existing internal financial resources [1] Group 2 - The company believes that the current trading price of its shares does not adequately reflect its intrinsic value [1] - The share repurchase is seen as a move to enhance the net asset value and earnings return per share, aligning with the best interests of the company and its shareholders [1]
海伦司(09869)决定行使回购股份授权
智通财经网· 2025-11-06 09:09
Core Viewpoint - The company, Helen's (09869), has received shareholder approval to repurchase up to 10% of its issued shares, amounting to a maximum of 127 million shares, reflecting confidence in its growth prospects and financial health [1] Group 1 - Shareholders approved a general and unconditional authorization for the board to repurchase shares at the annual general meeting on May 14, 2025 [1] - The repurchase authorization will expire upon the earliest occurrence of specific events, including the conclusion of the next annual general meeting in 2026 or the expiration of any applicable legal requirements [1] - On November 6, 2025, the board decided to exercise the share repurchase authorization, intending to buy back shares in the open market using existing internal financial resources [1] Group 2 - The company believes that the current trading price of its shares does not adequately reflect its intrinsic value [1] - The share repurchase is seen as a demonstration of the company's long-term confidence in its operational growth prospects and financial condition [1] - The initiative aims to enhance the net asset value and earnings return per share, aligning with the best interests of the company and its shareholders [1]
海伦司(09869.HK)拟在公开市场回购股份
Ge Long Hui· 2025-11-06 09:08
Core Viewpoint - The company, Helen's (09869.HK), announced a share buyback plan, indicating that the current trading price does not reflect its intrinsic value, demonstrating long-term confidence in its growth prospects and financial condition [1] Group 1 - The board of directors decided to exercise the share buyback authorization on November 6, 2025 [1] - The company plans to repurchase shares in the open market using existing internal financial resources [1] - The share buyback is expected to enhance the net asset value and earnings return per share, aligning with the best interests of the company and its shareholders [1]
海伦司(09869) - 自愿性公告 - 回购股份
2025-11-06 09:00
香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對本公 告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全 部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 Helens International Holdings Company Limited 海 倫 司 國 際 控 股 有 限 公 司 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) (香港股份代號:9869) (新加坡股份代號:HLS) 自願性公告 回購股份 本自願性公告乃海倫司國際控股有限公司(「本公司」)向其股東及其潛在投資 者提供關於本公司最新發展的資料而作出。 茲提述本公司日期為2025年4月23日的股東週年大會通函(「通函」)及日期為 2025年5月14日的股東週年大會的投票結果公告(「公告」),內容有關(其中包括) 建議授出回購股份之一般授權。除文義另有界定者外,本公告所用詞彙與通函 及公告所界定者具相同涵義。 股東已於2025年5月14日審議通過一般性及無條件給予董事一般授權,即回購 不超過股東週年大會當日已發行股份總數10%的股份(即不超過126 ...
海伦司(09869) - 截至二零二五年十月三十一日止股份发行人的证券变动月报表
2025-11-05 09:34
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致:香港交易及結算所有限公司 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09869 | 說明 | | | | | | | | | 已發行股份(不包括庫存股份)數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,265,477,524 | | 0 | | 1,265,477,524 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 1,265,477,524 | | 0 | | 1,265,477,524 | 公司名稱: 海倫司國際控股有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 ...
海伦司(09869) - 香港主要营业地点的变更
2025-10-30 09:00
香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對本公 告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全 部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 Helens International Holdings Company Limited 海 倫 司 國 際 控 股 有 限 公 司 (於開曼群島註冊成立的有限公司) (香港股份代號:9869) (新加坡股份代號:HLS) 香港主要營業地點的變更 海倫司國際控股有限公司(「本公司」)董事(「董事」)會(「董事會」)謹此宣佈, 自2025年10月30日起,本公司的香港主要營業地點已變更為香港九龍觀塘區偉 業街118號919室。 承董事會命 海倫司國際控股有限公司 董事會主席兼 行政總裁 徐炳忠先生 香港和新加坡,2025年10月30日 於本公告日期,執行董事為徐炳忠先生、蔡文君女士、余臻女士及賀大慶先生;以及獨立非執 行董事為李東先生、王仁榮先生及呂珣福先生。 ...
海伦司(09869) - 截至二零二五年九月三十日止股份发行人的证券变动月报表
2025-10-08 10:31
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 海倫司國際控股有限公司 呈交日期: 2025年10月8日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09869 | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000,000,000 | USD | | 0.0000000001 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 500,000,000,000,000 | USD | | 0.0000000001 | USD | ...